Contineum Therapeutics, Inc. Class A Common Stock Net Asset Quality Index
Contineum Therapeutics, Inc. Class A Common Stock net asset quality index. Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a Net Asset Quality Index of 95.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $250.37 Million minus total liabilities of $10.71 Million yields net assets of $239.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CTNM total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Contineum Therapeutics, Inc. Class A Common Stock (2021–2025)
Net asset quality index of Contineum Therapeutics, Inc. Class A Common Stock from 2021 to 2025. This chart shows how Contineum Therapeutics, Inc. Class A Common Stock's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 95.7%, representing net assets of $239.66 Million against total assets of $250.37 Million USD. Check tangible equity quality of Contineum Therapeutics, Inc. Class A Com to evaluate the tangible quality of the company's equity base.
Contineum Therapeutics, Inc. Class A Common Stock Net Asset Quality Index by Year (2021–2025)
Contineum Therapeutics, Inc. Class A Common Stock net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for Contineum Therapeutics, Inc. Class A Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Contineum Therapeutics, Inc. Class A Com market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.3% | $260.99 Million | $276.64 Million | $15.65 Million | ▲ +1.3 pp |
| 2024 | 93.1% | $198.07 Million | $212.85 Million | $14.78 Million | ▲ +145.2 pp |
| 2023 | -52.1% | $-67.94 Million | $130.39 Million | $198.32 Million | ▼ -129.7 pp |
| 2022 | 77.6% | $39.27 Million | $50.64 Million | $11.37 Million | ▼ -9.8 pp |
| 2021 | 87.3% | $61.59 Million | $70.52 Million | $8.93 Million | — |